Advertisement

Topics

Search Results for "Reminder Sample Letter Prostate Cancer"

00:19 EST 24th January 2017 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

Radioactive prostate cancer drug given approval for NHS use – The Independent

The IndependentRadioactive prostate cancer drug given approval for NHS useThe IndependentA radioactive drug, similar to that which killed Russian former spy Alexander Litvinenko has been approved as a...

What you need to know about prostate cancer – BT.com

BT.comWhat you need to know about prostate cancerBT.comProstate cancer kills 10,000 men a year and by 2030 it will be the most common of all cancers in the UK. We take a look at the signs and symptoms...

SEER Data Show Early Prostate Cancer Diagnoses Continue to Drop

Early-stage prostate cancer diagnoses have continued to decrease since the US Preventive Services Task Force (USPSTF) recommended against routine prostate specific antigen (PSA) testing in 2012, accor...

PSA: The Prostate Cancer Screening Test

Prostate cancer is the second most common cancer in American men, following skin cancer. One in every seven men will be diagnosed with this form of cancer in his lifetime; with the average age of diag...

For early prostate cancer, a watchful eye is just as good as treatment – Ars Technica

Ars TechnicaFor early prostate cancer, a watchful eye is just as good as treatmentArs TechnicaIn the wake of a cancer diagnosis, deciding to sit back and see how things play out may seem like a ballsy...

Pass it On: It’s National Prostate Cancer Awareness Month

Prostate cancer is the most common type of cancer in men other than skin cancer, and the second leading cause of death.  The American Cancer Society estimates that in 2015 there will be approximately...

Medical News Today: How to Improve Your Sex Life After Prostate Cancer

What is the prostate gland and how can prostate cancer affect sexual behavior? Learn how to manage your sex life after prostate cancer and its treatment.

Research helps explain why androgen-deprivation therapy doesn't work for many prostate cancers

Metastatic prostate cancer, or prostate cancer that has spread to other organs, is incurable. In new research published in the journal Science, Roswell Park Cancer Institute scientists have identified...

Matching PubMed Articles

Gene expression profile of FVII and AR in primary prostate cancer.

The ectopic expression of coagulation Factor VII has been shown in various cancers. Recently, F7 gene has been identified as a direct target of the androgen receptor in breast cancer. In this study, w...

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Protective effects have been suggested for digoxin against prostate cancer risk. However, few studies have evaluated the possible effects on prostate cancer-specific survival. We studied the associati...

Immune Checkpoint Therapies in Prostate Cancer.

Advanced prostate cancer is the second leading cause of death from cancer in the United States. In the era of cancer immunotherapy, it was the first malignancy to demonstrate improved survival with a ...

Prostate cancer.

Prostate cancer is the most frequent tumor found in men worldwide and in Mexico in particular. Age and family history are the main risk factors. The diagnosis is made by prostate biopsy in patients wi...

Sample preparation of serum to allow capillary electrophoresis analysis of prostate specific antigen isoforms.

Prostate cancer is the second most frequently diagnosed cancer in men worldwide. Currently prostate specific antigen (PSA) serum concentration is the most used prostate cancer marker, but it only show...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement